{'fraction_non_alphanumeric': 0.03205128205128205, 'fraction_numerical': 0.01987179487179487, 'mean_word_length': 5.09765625, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Stopped-flow chemiluminescence determination of the anticancer drug capecitabine: Application in pharmaceutical analysis and drug-delivery systems.

Capecitabine is a chemotherapeutic agent used for the treatment of patients with metastatic cancers. This study aimed at determining the drug capecitabine in a simple chemiluminescence (CL) system of acidic potassium permanganate using the stopped-flow injection technique. Statistical methods were used to detect optimum conditions. The method showed two linear calibration ranges from 6.7 × 10-6 to 6.7 × 10-5 mol L-1 and from 6.7 × 10-5 to 2.7 × 10-3 mol L-1 with a detection limit of 1.5 × 10-6 mol L-1 . Chitosan-modified magnetic nanoparticles were studied in the drug-delivery experiments. According to the pH sensitivity of chitosan and low pH values in tumour cells, the chitosan-coated magnetic nanoparticles could provide a good targeting drug-delivery system to tumour sites. To evaluate the applicability of the method, the capecitabine-loaded magnetic chitosan nanoparticles were synthesized with two different cross-linkers; loading and releasing rates of the drug were investigated using the proposed CL method and an ultraviolet-visible light spectrophotometric method (absorption at 305 nm). The results showed a good correlation between the two methods, and it was found that the synthesized chitosan-modified magnetic nanoparticles could be used for pH-dependent release of capecitabine in cancer cells. Moreover, determination of capecitabine in tablets and synthetic samples was performed.